{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:43Z","timestamp":1791337963985,"version":"4.3.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral anticoagulants, including warfarin and direct oral anticoagulants (DOACs), are widely used for the prevention and treatment of thromboembolic disorders. Community pharmacists are accessible healthcare professionals who may support safe use through counselling on adherence, interactions, adverse effects, and monitoring requirements. This study assessed community pharmacists\u2019 knowledge, attitudes, awareness, and practice-related responses regarding warfarin and DOACs and examined factors associated with knowledge scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study was conducted among community pharmacists working in the northern West Bank, Palestine, between October 2022 and March 2023. A total of 340 pharmacists were approached, and 329 completed the questionnaire (response rate: 96.8%). Data were collected using a structured 70-item questionnaire covering sociodemographic and professional characteristics, knowledge, awareness and attitudes, and practice-related items. Descriptive statistics were used to summarize participant characteristics and questionnaire responses. Knowledge scores were compared across subgroups using Mann-Whitney U and Kruskal-Wallis tests, and multivariable linear regression was used to examine independent associations with knowledge scores. A p value\u2009&lt;\u20090.05 was considered statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 329 pharmacists with a mean age of 33.64 years; 70.5% were women and 80.9% held a bachelor\u2019s degree in pharmacy. Warfarin (Coumadin 5\u00a0mg) was available in 87.8% of participating pharmacies. Across knowledge items, 49.1% of responses were correct. Only 48.6% correctly recognized that missing a single DOAC dose could worsen a patient\u2019s condition, and 49.2% selected \u201cdo not know\u201d regarding the interaction of apixaban or rivaroxaban with St. John\u2019s wort. For warfarin, 84.8% recognized potential dietary interactions and 84.2% recognized the importance of international normalized ratio (INR) monitoring, whereas only 35.3% identified vitamin K as a reversal option for excessive warfarin anticoagulation or bleeding. In univariable analyses, no statistically significant differences in knowledge scores were observed according to sociodemographic or professional characteristics (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). Consistent with these findings, the multivariable model was not statistically significant, and no independent predictors of knowledge score were identified.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Community pharmacists in the northern West Bank showed suboptimal knowledge regarding oral anticoagulants, with important gaps related to DOAC reversal agents, drug and herbal interactions, and missed-dose counselling. No independent predictors of knowledge score were identified, suggesting that educational needs are broadly distributed among pharmacists. Targeted continuing education focused on practical anticoagulant counselling and medication-safety issues may strengthen pharmacists\u2019 contribution to safer oral anticoagulant use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40780-026-00607-w","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:15:47Z","timestamp":1783736147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of community pharmacists\u2019 knowledge, attitudes, awareness, and practice-related responses regarding oral anticoagulants in the Northern West Bank, Palestine: a cross-sectional study"],"prefix":"10.1186","volume":"12","author":[{"given":"Hanan M.","family":"Alayyad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saja W.","family":"Abu Arqoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak A.","family":"Abuobaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina H.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer A.","family":"Koni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Abuhalima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah W.","family":"Al-Jabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banan M.","family":"Aiesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u2019ed H.","family":"Zyoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"4","key":"607_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/medicines6040103","volume":"6","author":"SA Kustos","year":"2019","unstructured":"Kustos SA, Fasinu PS. Direct-Acting Oral Anticoagulants and Their Reversal Agents\u2014An Update. Medicines. 2019;6(4):103.","journal-title":"Medicines"},{"issue":"13","key":"607_CR2","doi-asserted-by":"publisher","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","volume":"9","author":"A Chen","year":"2020","unstructured":"Chen A, Stecker E, Warden BA. Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges. J Am Heart Assoc. 2020;9(13):e017559.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"607_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/biomedicines9050445","volume":"9","author":"C Dunois","year":"2021","unstructured":"Dunois C. Laboratory Monitoring of Direct Oral Anticoagulants (DOACs). Biomedicines. 2021;9(5):445.","journal-title":"Biomedicines"},{"issue":"Suppl 1","key":"607_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ijlh.12992","volume":"41","author":"RC Gosselin","year":"2019","unstructured":"Gosselin RC, Adcock DM, Douxfils J. An update on laboratory assessment for direct oral anticoagulants (DOACs). Int J Lab Hematol. 2019;41(Suppl 1):33\u20139.","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"607_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s11239-021-02416-4","volume":"52","author":"S Afzal","year":"2021","unstructured":"Afzal S, Zaidi STR, Merchant HA, Babar ZU, Hasan SS. Prescribing trends of oral anticoagulants in England over the last decade: a focus on new and old drugs and adverse events reporting. J Thromb Thrombolysis. 2021;52(2):646\u201353.","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"607_CR6","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jamaneurol.2019.2099","volume":"76","author":"Y Xian","year":"2019","unstructured":"Xian Y, Xu H, O\u2019Brien EC, Shah S, Thomas L, Pencina MJ, Fonarow GC, Olson DM, Schwamm LH, Bhatt DL, et al. Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study. JAMA Neurol. 2019;76(10):1192\u2013202.","journal-title":"JAMA Neurol"},{"issue":"1","key":"607_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40545-021-00377-w","volume":"14","author":"SL Tan","year":"2021","unstructured":"Tan SL, Yong ZY, Liew JES, Zainal H, Siddiqui S. How confident are pharmacists in providing pharmaceutical care on anticoagulants? A cross-sectional, self-administered questionnaire study in Borneo, Malaysia. J Pharm Policy Pract. 2021;14(1):97.","journal-title":"J Pharm Policy Pract"},{"issue":"4","key":"607_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.blre.2017.02.001","volume":"31","author":"A Di Minno","year":"2017","unstructured":"Di Minno A, Frigerio B, Spadarella G, Ravani A, Sansaro D, Amato M, Kitzmiller JP, Pepi M, Tremoli E, Baldassarre D. Old and new oral anticoagulants: Food, herbal medicines and drug interactions. Blood Rev. 2017;31(4):193\u2013203.","journal-title":"Blood Rev"},{"key":"607_CR9","unstructured":"Patel S, Singh R, Preuss CV, Patel N. Warfarin. edn. Treasure island (FL): StatPearls Publishing: Copyright \u00a9 2023."},{"issue":"1","key":"607_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11239-015-1319-y","volume":"41","author":"DM Witt","year":"2016","unstructured":"Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE. Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):187\u2013205.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"607_CR11","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.18549\/PharmPract.2022.4.2741","volume":"20","author":"AM Alkherat","year":"2022","unstructured":"Alkherat AM, Alkhalidi DK. Assessment of knowledge and counseling practice of warfarin among pharmacists in UAE: A cross-sectional study. Pharm Pract (Granada). 2022;20(4):2741.","journal-title":"Pharm Pract (Granada)"},{"issue":"9","key":"607_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7326\/0003-4819-121-9-199411010-00009","volume":"121","author":"PS Wells","year":"1994","unstructured":"Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med. 1994;121(9):676\u201383.","journal-title":"Ann Intern Med"},{"issue":"10","key":"607_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","volume":"165","author":"AM Holbrook","year":"2005","unstructured":"Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165(10):1095\u2013106.","journal-title":"Arch Intern Med"},{"key":"607_CR14","doi-asserted-by":"publisher","first-page":"107602962093394","DOI":"10.1177\/1076029620933946","volume":"26","author":"A El-Bardissy","year":"2020","unstructured":"El-Bardissy A, Elewa H, Khalil A, Mekkawi W, Mohammed S, Kassem M, Alma\u2019moon MM, Abdelgelil M, Eltorki Y, Mohamed FAA. Assessing Pharmacists Knowledge and Attitude Toward the Direct Oral Anticoagulants in Qatar. Clin Appl Thromb Hemost. 2020;26:1076029620933946.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"607_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2125.2006.02806.x","volume":"62","author":"M Pirmohamed","year":"2006","unstructured":"Pirmohamed M. Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol. 2006;62(5):509\u201311.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"607_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4103\/jpbs.JPBS_233_19","volume":"12","author":"AA Mohamed","year":"2020","unstructured":"Mohamed AA, Alnewais ME, Ibrahim YA, Zaitoun MF. Pharmacists\u2019 warfarin therapy knowledge and counseling practices in the Eastern Province, Saudi Arabia: A cross-sectional study. J Pharm Bioallied Sci. 2020;12(3):289\u201394.","journal-title":"J Pharm Bioallied Sci"},{"issue":"3","key":"607_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10928-021-09783-8","volume":"49","author":"M Bontempi","year":"2022","unstructured":"Bontempi M. Semi-empirical anticoagulation model (SAM): INR monitoring during Warfarin therapy. J Pharmacokinet Pharmacodyn. 2022;49(3):271\u201382.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"607_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12872-019-1078-3","volume":"19","author":"I Kamthornthanakarn","year":"2019","unstructured":"Kamthornthanakarn I, Krittayaphong R. Optimal INR level for warfarin therapy after mechanical mitral valve replacement. BMC Cardiovasc Disord. 2019;19(1):97.","journal-title":"BMC Cardiovasc Disord"},{"key":"607_CR19","doi-asserted-by":"crossref","unstructured":"Ferri N, Colombo E, Tenconi M, Baldessin L, Corsini A. Drug-drug interactions of direct oral anticoagulants (DOACs): From pharmacological to clinical practice. Pharmaceutics. 2022;14(6).","DOI":"10.3390\/pharmaceutics14061120"},{"key":"607_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fneur.2018.01067","volume":"9","author":"A Galgani","year":"2018","unstructured":"Galgani A, Palleria C, Iannone LF, De Sarro G, Giorgi FS, Maschio M, Russo E. Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs. Front Neurol. 2018;9:1067.","journal-title":"Front Neurol"},{"issue":"4","key":"607_CR21","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1111\/bcp.15106","volume":"88","author":"A Capiau","year":"2022","unstructured":"Capiau A, Mehuys E, Dhondt E, De Backer T, Boussery K. Physicians\u2019 and pharmacists\u2019 views and experiences regarding use of direct oral anticoagulants in clinical practice. Br J Clin Pharmacol. 2022;88(4):1856\u201365.","journal-title":"Br J Clin Pharmacol"},{"key":"607_CR22","doi-asserted-by":"publisher","first-page":"675200","DOI":"10.3389\/fcvm.2021.675200","volume":"8","author":"Y Wu","year":"2021","unstructured":"Wu Y, Zhang C, Gu ZC. Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World Setting. Front Cardiovasc Med. 2021;8:675200.","journal-title":"Front Cardiovasc Med"},{"issue":"36","key":"607_CR23","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, De Potter TJR, Dwight J, Guasti L, Hanke T, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"6","key":"607_CR24","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","volume":"160","author":"SM Stevens","year":"2021","unstructured":"Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545\u2013608.","journal-title":"Chest"},{"issue":"19","key":"607_CR25","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, Hutten BA, Jaff MR, Manja V, Schulman S, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693\u2013738.","journal-title":"Blood Adv"},{"issue":"3","key":"607_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11239-016-1465-x","volume":"43","author":"HA Hakeam","year":"2017","unstructured":"Hakeam HA, Al-Sanea N. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs). J Thromb Thrombolysis. 2017;43(3):343\u201351.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"607_CR27","first-page":"1215","volume":"26","author":"L Tahaineh","year":"2022","unstructured":"Tahaineh L, Ali T. Community pharmacists\u2019 knowledge of direct oral anticoagulants and warfarin in the North of Jordan: a cross sectional study. Eur Rev Med Pharmacol Sci. 2022;26(4):1215\u201323.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"607_CR28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s11096-017-0551-2","volume":"39","author":"J Papastergiou","year":"2017","unstructured":"Papastergiou J, Kheir N, Ladova K, Rydant S, De Rango F, Antoniou S, Viola R, Murillo MD, Steurbaut S. da Costa FA: Pharmacists\u2019 confidence when providing pharmaceutical care on anticoagulants, a multinational survey. Int J Clin Pharm. 2017;39(6):1282\u201390.","journal-title":"Int J Clin Pharm"},{"key":"607_CR29","unstructured":"Ministry of Health. Health Annual, Report P. 2021. 2022. https:\/\/site.moh.ps\/index\/Books\/BookType\/2\/Language\/ar. Accessed 28 May 2025."},{"issue":"9suppl","key":"607_CR30","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.1177\/1076029618807575","volume":"24","author":"A El-Bardissy","year":"2018","unstructured":"El-Bardissy A, Elewa H, Mohammed S, Shible A, Imanullah R, Mohammed AM. A Survey on the Awareness and Attitude of Physicians on Direct Oral Anticoagulants in Qatar. Clin Appl Thromb Hemost. 2018;24(9suppl):S255\u201360.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"607_CR31","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s11239-020-02111-w","volume":"50","author":"I Eljilany","year":"2020","unstructured":"Eljilany I, El-Bardissy A, Nemir A, Elzouki AN, El Madhoun I, Al-Badriyeh D, Elewa H. Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey. J Thromb Thrombolysis. 2020;50(4):957\u201368.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"607_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ctcp.2006.06.002","volume":"12","author":"JT Saw","year":"2006","unstructured":"Saw JT, Bahari MB, Ang HH, Lim YH. Potential drug-herb interaction with antiplatelet\/anticoagulant drugs. Complement Ther Clin Pract. 2006;12(4):236\u201341.","journal-title":"Complement Ther Clin Pract"},{"issue":"2","key":"607_CR33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/bcp.14404","volume":"87","author":"CSS Tan","year":"2021","unstructured":"Tan CSS, Lee SWH. Warfarin and food, herbal or dietary supplement interactions: A systematic review. Br J Clin Pharmacol. 2021;87(2):352\u201374.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"607_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12959-022-00374-2","volume":"20","author":"SW Al-Jabi","year":"2022","unstructured":"Al-Jabi SW, Dalu AA, Koni AA, Khdour MR, Taha AA, Amer R, Zyoud SH. The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country. Thromb J. 2022;20(1):15.","journal-title":"Thromb J"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-026-00607-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:41:42Z","timestamp":1791337302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40780-026-00607-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["607"],"URL":"https:\/\/doi.org\/10.1186\/s40780-026-00607-w","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of An-Najah National University (IRB reference number: Ph.D. Sep. 2022\/31). Eligible pharmacists received an explanation of the study objectives and provided verbal informed consent before participation. The IRB approved the use of verbal consent because participation involved questionnaire completion without intervention and confidentiality was maintained. All methods were conducted in accordance with relevant ethical guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"85"}}